Pages that link to "Q40005392"

The following pages link to Rifampicin, a general review (Q40005392):

Displaying 37 items.

• Serum concentration and half-life of rifampicin after simultaneous oral administration of aminosalicylic acid or isoniazid (Q28246348) (← links)
• Antimycobacterial activity of a new rifamycin derivative, 3-(4-cinnamylpiperazinyl iminomethyl) rifamycin SV (T9) (Q28378827) (← links)
• Effect of Rifampin on Nasal Carriage of Staphylococcus aureus (Q30449230) (← links)
• Characteristics of rifampin-resistant variants obtained from clinical isolates of Staphylococcus aureus (Q30451383) (← links)
• Modulation of rifampicin toxicity by 6 MFA, an interferon inducer obtained from fungus Aspergillus ochraceus (Q33396320) (← links)
• Prevention of hydrocephalus shunt catheter colonisation in vitro by impregnation with antimicrobials. (Q33628893) (← links)
• Mechanisms and prediction of drug-induced liver disease (Q34475857) (← links)
• Serum concentrations and bioavailability of rifampicin and isoniazid in combination (Q34515325) (← links)
• The effect of rifampicin on sulphapyridine plasma concentrations following sulphasalazine administration (Q34622597) (← links)
• Antituberculosis Drug-Induced Hepatotoxicity in Children (Q35096954) (← links)
• Predicting differential rifamycin resistance in clinical Mycobacterium tuberculosis isolates by specific rpoB mutations. (Q36169719) (← links)
• Genetic analysis of Staphylococcus aureus RNA polymerase mutants (Q36340898) (← links)
• Evidence that rifampicin can be used safely for non-tuberculous diseases (Q36465346) (← links)
• Growth Conditions and Rifampin Susceptibility (Q36478271) (← links)
• Antimicrobial susceptibility testing of pneumococci: determination of Kirby-Bauer breakpoints for penicillin G, erythromycin, clindamycin, tetracycline, chloramphenicol, and rifampin (Q36482605) (← links)
• Population pharmacokinetics of rifampin in pulmonary tuberculosis patients, including a semimechanistic model to describe variable absorption (Q36702972) (← links)
• Absorption, disposition, and urinary metabolism of 14C-rifabutin in rats (Q36754173) (← links)
• A physiologically based pharmacokinetic model of rifampin in mice. (Q36757635) (← links)
• Adequacy of Rifampin Absorption after Jejunostomy Tube Administration. (Q37352344) (← links)
• Rifampin combination therapy for nonmycobacterial infections (Q37672039) (← links)
• The chemotherapy of tuberculous meningitis in children and adults (Q37784590) (← links)
• The pharmacokinetics and pharmacodynamics of rifampicin in adults and children in relation to the dosage recommended for children (Q37856552) (← links)
• The emergence of antibiotic resistance: myths and facts in clinical practice (Q38035295) (← links)
• Brucella endocarditis (Q39672692) (← links)
• Clinical Pharmacokinetics of Rifampicin (Q39720647) (← links)
• Rifampin plus trimethoprim: bactericidal activity and suppression of resistance in human urine in vitro (Q40621385) (← links)
• Successful treatment of brucella melitensis endocarditis (Q40875911) (← links)
• Tissue Distribution of 14C-Rifampicin I. Whole Body Autoradiography of Albino Mice (Q42007757) (← links)
• Antistaphylococcal activity of dihydrophthalazine antifolates, a family of novel antibacterial drugs (Q42037140) (← links)
• Combination Susceptibility Testing of Common Antimicrobials in Vitro and the Effects of Sub-MIC of Antimicrobials on Staphylococcus aureus Biofilm Formation (Q46107780) (← links)
• Testing of rifampicin on possible genetic effects on Drosophila melanogaster and human leukocyte chromosomes in vitro. (Q52470538) (← links)
• Rifampicin in plasma and pleural fluid after single oral doses. (Q54471467) (← links)
• Time Series Analysis of the Microbiota of Children Suffering From Acute Infectious Diarrhea and Their Recovery After Treatment. (Q55396690) (← links)
• Pharmacokinetics of oral and intravenous rifampicin during chronic administration (Q56832437) (← links)
• Binding of rifampicin by human plasma proteins. (Q64949156) (← links)
• Tissue Distribution of 14C-Rifampicin II. Accumulation in Melanin-containing Structures (Q67312499) (← links)
• Bioequivalence study of two pharmaceutical forms of rifampicin capsules in man (Q71946110) (← links)